|
|
![]() |
IMPORTANT SAFETY INFORMATION More helpful facts about SELZENTRY will be coming to this Web site soon. Check back to learn more about the benefits and risks of SELZENTRY. If you have questions about SELZENTRY and want to know if it may be right for you, talk to your doctor. Your doctor can help explain how SELZENTRY might fit into your treatment plan. Indication Selzentry® (maraviroc) is a CCR5 inhibitor that is used with other HIV medicines to treat CCR5-tropic HIV. Selzentry is not recommended in patients with dual/mixed or CXCR4-tropic HIV. It is for adult patients with CCR5-tropic HIV only. A Tropism test is needed before starting Selzentry. Selzentry does not cure HIV infection or AIDS and does not lower the risk of passing HIV to other people. People taking SELZENTRY may still develop infections, including opportunistic infections or other conditions that happen with HIV infection. The long-term effects of SELZENTRY are not known at this time. It is very important that you stay under the care of your health care provider during treatment with SELZENTRY. IMPORTANT SAFETY INFORMATION Before you take SELZENTRY, tell your health care provider if you have liver problems including a history of hepatitis B or C, have heart problems, have kidney problems, have low blood pressure or take medicines to lower blood pressure, have any other medical condition, are pregnant or plan to become pregnant, are breastfeeding or plan to breastfeed. People with severe kidney problems or who are on hemodialysis and are taking certain other medications should not take SELZENTRY. Talk to your healthcare provider before taking this medicine if you have kidney problems Possible serious side effects of SELZENTRY include:
MOST COMMON SIDE EFFECTS DRUG INTERACTIONS |
||
![]() |
![]() |
![]() |
||
|
You are encouraged to report negative side effects of prescription drugs to the FDA. | ||||